Reports and presentations

December 10, 2024

66^th American Society of Hematology Annual Meeting

Link to the Webcast
Link to the Poster

October 22, 2024

Faron Capital Markets Day 2024

Link to the Webcast
Link to the Presentation

October 9, 2024

Proactive One2One Biotech Investor Forum

Link to the Webcast

July 11, 2024

FDA Feedback Update

Link to the Presentation

June 4, 2024

Share offering

May 22, 2024

BEXMAB Study Update

Link to the Presentation

March 19, 2024

BEXMAB Study Update

Link to the Presentation

January 11, 2024

J.P. Morgan Healthcare Conference

Link to the Presentation
Link to the Presented Deck

December 9-12, 2023

ASH 2023 Annual Meeting

Link to the Poster

October 20-24, 2023

ESMO Congress 2023

Link to the Poster

September 12, 2023

H.C. Wainwright 25th Annual Global Investment Conference – September 11-13, 2023

Link to the Webcast

August 10, 2023

Faron Participation at Canaccord Genuity 43rd Annual Growth Conference

Link to the Presentation

July 19, 2023

BEXMAB Study Update

Link to the Presentation

Link to the Webcast

May 31, 2023

European Hematology Association Meeting 2023 – Poster

Link to the Poster

April 25, 2023

Bexmarilimab for Hematological Malignancies KOL Event

Link to the Recording

March 3, 2023

Faron Financial Statement 2022 Webcast

Link to the Webcast

December 13, 2022

Faron as an Investment | Company Night Dec. 13, 2022

Link to the Webcast

November 28, 2022

Redeye Life Science Day 2022

Link to the Q&A

Link to the Prerecorded Video

September 21, 2022

Faron to Host Bexmarilimab Update Webcast

Link to the Webcast

September 13, 2022

Pörssisijoittajan viikko – Faron sijoituskohteena

Toimitusjohtaja Markku Jalkasen esitys katsottavissa linkistä

September 12, 2022

H.C. Wainwright 24th Annual Global Investment Conference – September 12-14, 2022

On-demand presentation is available starting Monday,
Sep 12, 2022 at 7:00 am EDT / 12:00 pm GMT / 2:00 pm EET

Admission document